Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer.
A growing body of evidence suggests that prostate-specific antigen (PSA) is a novel prognostic factor for breast cancer. The molecular mechanism of variant PSA expression in breast cancer has remained poorly understood in spite of intensive research. Previous studies have shown that the coding region of the PSA gene is not a target for mutations in prostate cancer and breast cancer. The purpose of this study was to analyze genetic variations in the promoter region of the PSA gene, and to detect whether such variations are correlated with PSA mRNA expression in breast tumors. We identified two polymorphisms in the proximal promoter region of the PSA gene. These polymorphisms are located at positions -252 (G or A) and -205 (A or AA), and generate three genotypes. The genotypes were associated with PSA mRNA expression. Our findings suggest that these polymorphisms identified in the proximal promoter region may affect the transcriptional activity of PSA.
Yang
Q F
QF
Second Department of Pathology, Wakayama Medical College, Japan. yang-qf@mail.wakayama-med.ac.jp
Sakurai
T
T
Shan
L
L
Yu
Z
Z
Yoshimura
G
G
Suzuma
T
T
Tamaki
T
T
Umemura
T
T
Nakamura
M
M
Nakamura
Y
Y
Mori
I
I
Kakudo
K
K
D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D006801:Humans; D018807:Polymorphism, Single-Stranded Conformational; D017430:Prostate-Specific Antigen / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
D012333:RNA, Messenger; D017430:Prostate-Specific Antigen